willow

(redirected from Salix)
Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to Salix: Salix alba, Slackware

wil·low

(wil'ō),
A tree of the genus Salix; the bark of several species, especially S. fragilis, is a source of salicin.
[A.S. welig]

willow

/wil·low/ (wil´o) any plant of the genus Salix. White willow bark (q.v.) contains a precursor of salicylic acid and is used as an herbal remedy.

willow,

n Latin name:
Salix spp.; part used: bark; uses: analgesic, antiinflammatory, general health, bursitis, antipyretic, tension headache, osteoarthritis, rheumatoid arthritis, gastrointestinal disorders; precautions: can cause allergic skin reactions, bronchospasm, stomach ulcers, nausea, or diarrhea. Also called
white willow and
european willow.
References in periodicals archive ?
This revised offer provides Salix shareholders with all-cash at a significant premium and the certainty to close by April 1.
Following the proposed merger agreement between Salix and Cosmo Pharmaceuticals S.
We are firmly committed to our all-cash agreed transaction, which delivers immediate and certain value to Salix shareholders.
When granted by the court, Salix's January 5, 2012 motion to dismiss the lawsuit will establish Napo as the prevailing party in the lawsuit filed by Salix on June 22, 2011.
Under the terms of the agreement, public shareholders of Salix would receive $158.
Michael Freeman, Associate Vice President of Investor Relations and Corporate Communications for Salix.
The growing GI market has attractive fundamentals, and Salix has a portfolio of terrific products that are outpacing the market in terms of volume growth and a promising near-term pipeline of innovative products.
In connection with this offering, Salix entered into capped call transactions with certain underwriters in the offering or their respective affiliates.
Under the terms of the agreement, Salix will become a wholly-owned subsidiary of Irish domiciled Cosmo Tech, which will change its name to Salix Pharmaceuticals, plc and is expected to have its ordinary shares listed and traded on the NASDAQ Global Select Market.